Smaller tumors had significantly higher CD45+ immune cell infiltration (Figure 8H), resulting in significantly higher CD8+ and CD8−CD4− (possibly γδ) T cell fractions, higher CD11b+ myeloid fractions, including F4/80+ Mφ, and a trend of higher B cells and M2-like Mφ as fraction of total cells in the tumor (Figures 8I, 8J, and S9L). The gene discussed is PTPRC; the disease is neoplasm.